JMD - The Journal of Molecular Diagnostics
The Journal of Molecular Diagnostics (JMD) publishes high-quality original papers on scientific advances in the translation and validation of molecular discoveries in medicine into the clinical diagnostic setting, and the description and application of technological advances in the field of molecular diagnostic medicine. The impact factor is 5.553.*
Articles report novel discoveries with direct application to clinical diagnostics or clinicopathologic correlations including studies in oncology, infectious diseases, inherited diseases, predisposition to disease, clinical informatics, or the description of polymorphisms linked to disease states or normal variations; the application of diagnostic methodologies in clinical trials; and the development of new or improved molecular methods for diagnosis or monitoring of disease or disease predisposition.
Special Features include Technical Advances, a peer-reviewed section featuring novel methods to solve diagnostic dilemmas. Reviews, Commentaries, and Special Articles provide focus on controversial or "hot" research topics and issues.
JMD now publishing 12 issues a year!
In 2020, JMD increased publication to release 12 issues per year!
New submissions to The Journal of Molecular Diagnostics should be submitted on the Editorial Manager submission and review platform.
Author Benefits
- 2019 impact factor: 5.5553*
- 2019 5-year impact factor: 5.518
- Eigen factor: 0.00097
- 2019 CiteScore: 8.2
- Top 15 Pathology journal*
- Online Manuscript Submission with Editorial Manager.
- Articles in Press - advance publication online before print
- Authors entitled to 1 FREE electronic reprint
- New Discounts for Authors! ASIP Regular Members receive an Author-discount on publication charges and no color charge.
- Indexed in all major indexing services (NLM's MEDLINE/PubMed, Thomson's Science Scitation, EMBASE, SCOPUS)
Reader Benefits
- Published bimonthly (Jan, Mar, May, July, Sep, Nov) in print and online at https://jmd.amjpathol.org
- The latest translational research and technical advances across diverse fields of clinical medicine
- Features Reviews, Commentaries, Technical Advances, and Special Articles - the latest diagnostic perspectives and AMP-sponsored guidelines
- Distinguished Editorial Board includes internationally recognized scientists and leading diagnostics researchers
- 2021 JMD CME Program in Molecular Diagnostics - earn up to 18 credits/year
- Free online access to all legacy content (12 months or older)
- Free email alerts of new content as it is published
*Thomson Reuters Citation Report 2019
Editor-in-Chief:
Barbara Zehnbauer, PhD
Emory University School of Medicine
JMD is co-owned by ASIP with the Association for Molecular Pathology (AMP), and published by Elsevier
JMD Online (Member Access)
JMD Online (Non-Member Access)
Contact the Editorial Office: jmd@asip.org
JMD Editorial Board Conflict-of- Interest Disclosures Form (MSWordDoc)
JMD Scientific Integrity Policy: Editor Conduct (PDF)
Follow JMD 
JMD iPad app now available! Updated FREE benefit to members and journal subscribers. Click here for access instructions and details.